Trial Profile
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2019
Price :
$35
*
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 19 Feb 2019 According to an Aclaris Therapeutics media release, data from the study will be presented at the 77th Annual Meeting of the American Academy of Dermatology (AAD) 2019.
- 28 Mar 2018 Status changed from active, no longer recruiting to completed.
- 19 Mar 2018 3 month follow-up results presented in the Aclaris Therapeutics media release.